
Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia
Author(s) -
Jianming Guo,
Rong Tang
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000026955
Subject(s) - doxazosin , medicine , tamsulosin , tolerability , lower urinary tract symptoms , international prostate symptom score , urology , cochrane library , adverse effect , meta analysis , randomized controlled trial , hyperplasia , prostate , blood pressure , cancer